
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 29, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 60 mg".
Filed with NSE ·

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 29, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 60 mg".
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals